{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:47:06Z","timestamp":1790434026068,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM131216"],"award-info":[{"award-number":["GM131216"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM108921"],"award-info":[{"award-number":["GM108921"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Serotonin receptor (5-HT<jats:sub>3A<\/jats:sub>R) is the most common therapeutic target to manage the nausea and vomiting during cancer therapies and in the treatment of irritable bowel syndrome. Setrons, a class of competitive antagonists, cause functional inhibition of 5-HT<jats:sub>3A<\/jats:sub>R in the gastrointestinal tract and brainstem, acting as effective anti-emetic agents. Despite their prevalent use, the molecular mechanisms underlying setron binding and inhibition of 5-HT<jats:sub>3A<\/jats:sub>R are not fully understood. Here, we present the structure of granisetron-bound full-length 5-HT<jats:sub>3A<\/jats:sub>R solved by single-particle cryo-electron microscopy to 2.92\u2009\u00c5 resolution. The reconstruction reveals the orientation of granisetron in the orthosteric site with unambiguous density for interacting sidechains. Molecular dynamics simulations and electrophysiology confirm the granisetron binding orientation and the residues central for ligand recognition. Comparison of granisetron-bound 5-HT<jats:sub>3A<\/jats:sub>R with the apo and serotonin-bound structures, reveals key insights into the mechanism underlying 5-HT<jats:sub>3A<\/jats:sub>R inhibition.<\/jats:p>","DOI":"10.1038\/s41467-019-11142-8","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:03:00Z","timestamp":1563530580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4018-8020","authenticated-orcid":false,"given":"Sandip","family":"Basak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Gicheru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-8276","authenticated-orcid":false,"given":"Marta","family":"Filizola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Chakrapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"11142_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2147\/CMAR.S166912","volume":"10","author":"J Gilmore","year":"2018","unstructured":"Gilmore, J., D\u2019Amato, S., Griffith, N. & Schwartzberg, L. Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists. Cancer Manag. Res. 10, 1827\u20131857 (2018).","journal-title":"Cancer Manag. Res."},{"key":"11142_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1126\/science.1718042","volume":"254","author":"AV Maricq","year":"1991","unstructured":"Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M. & Julius, D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254, 432 (1991).","journal-title":"Science"},{"key":"11142_CR3","doi-asserted-by":"publisher","unstructured":"Engel, M., Smidt, M. & Van Hooft, J. The serotonin 5-HT3 receptor: a novel neurodevelopmental target. Front. Cell. Neurosci. 7, https:\/\/doi.org\/10.3389\/fncel.2013.00076 (2013).","DOI":"10.3389\/fncel.2013.00076"},{"key":"11142_CR4","doi-asserted-by":"publisher","first-page":"40239","DOI":"10.1074\/jbc.R112.406496","volume":"287","author":"SCR Lummis","year":"2012","unstructured":"Lummis, S. C. R. 5-HT3 Receptors. J. Biol. Chem. 287, 40239\u201340245 (2012).","journal-title":"J. Biol. Chem."},{"key":"11142_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00001756-199501000-00008","volume":"6","author":"HK Kia","year":"1995","unstructured":"Kia, H. K. et al. Localization of 5-HT3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization. Neuroreport 6, 257\u2013261 (1995).","journal-title":"Neuroreport"},{"key":"11142_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ph4040603","volume":"4","author":"C B\u00e9try","year":"2011","unstructured":"B\u00e9try, C. et al. Role of 5-HT(3) receptors in the antidepressant response. Pharmaceuticals 4, 603\u2013629, https:\/\/doi.org\/10.3390\/ph4040603 (2011).","journal-title":"Pharmaceuticals"},{"key":"11142_CR7","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.2174\/138161206778522029","volume":"12","author":"AJ Thompson","year":"2006","unstructured":"Thompson, A. J. & Lummis, S. C. 5-HT3 receptors. Curr. Pharm. Des. 12, 3615\u20133630 (2006).","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl. 7","key":"11142_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","volume":"20","author":"MD Gershon","year":"2004","unstructured":"Gershon, M. D. Review article: serotonin receptors and transporters\u2014roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 20(Suppl. 7), 3\u201314 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"11142_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1517\/14728222.11.4.527","volume":"11","author":"AJ Thompson","year":"2007","unstructured":"Thompson, A. J. & Lummis, S. C. The 5-HT3 receptor as a therapeutic target. Expert Opin. Ther. Targets 11, 527\u2013540 (2007).","journal-title":"Expert Opin. Ther. Targets"},{"key":"11142_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1568007043482624","volume":"3","author":"B Costall","year":"2004","unstructured":"Costall, B. & Naylor, R. J. 5-HT3 receptors. Current drug targets. CNS Neurol. Disord. 3, 27\u201337 (2004).","journal-title":"CNS Neurol. Disord."},{"key":"11142_CR11","first-page":"1009","volume":"3","author":"MS Aapro","year":"2007","unstructured":"Aapro, M. S. Palonosetron as an anti-emetic and anti-nausea agent in oncology. Ther. Clin. Risk Manag. 3, 1009\u20131020 (2007).","journal-title":"Ther. Clin. Risk Manag."},{"key":"11142_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuropharm.2013.05.010","volume":"73","author":"SC Lummis","year":"2013","unstructured":"Lummis, S. C. & Thompson, A. J. Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors. Neuropharmacology 73, 241\u2013246 (2013).","journal-title":"Neuropharmacology"},{"key":"11142_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coph.2011.02.005","volume":"11","author":"RC Spiller","year":"2011","unstructured":"Spiller, R. C. Targeting the 5-HT3 receptor in the treatment of irritable bowel syndrome. Curr. Opin. Pharmacol. 11, 68\u201374 (2011).","journal-title":"Curr. Opin. Pharmacol."},{"key":"11142_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MJT.0b013e3181ea7821","volume":"17","author":"ES Hsu","year":"2010","unstructured":"Hsu, E. S. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am. J. Ther. 17, 476\u2013486 (2010).","journal-title":"Am. J. Ther."},{"key":"11142_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1021\/bi051676f","volume":"45","author":"PR Joshi","year":"2006","unstructured":"Joshi, P. R. et al. Interactions of granisetron with an agonist-free 5-HT3A receptor model. Biochemistry 45, 1099\u20131105 (2006).","journal-title":"Biochemistry"},{"key":"11142_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1081\/RRS-120025568","volume":"23","author":"G Maksay","year":"2003","unstructured":"Maksay, G., Bik\u00e1di, Z. & Simonyi, M. Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models. J. Recept. Signal Transduct. 23, 255\u2013270 (2003).","journal-title":"J. Recept. Signal Transduct."},{"key":"11142_CR17","doi-asserted-by":"publisher","first-page":"20476","DOI":"10.1074\/jbc.M413610200","volume":"280","author":"AJ Thompson","year":"2005","unstructured":"Thompson, A. J. et al. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. J. Biol. Chem. 280, 20476\u201320482 (2005).","journal-title":"J. Biol. Chem."},{"key":"11142_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/mol.105.011957","volume":"68","author":"D Yan","year":"2005","unstructured":"Yan, D. & White, M. M. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor. Mol. Pharm. 68, 365\u2013371 (2005).","journal-title":"Mol. Pharm."},{"key":"11142_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/embor.2012.189","volume":"14","author":"D Kesters","year":"2013","unstructured":"Kesters, D. et al. Structural basis of ligand recognition in 5-HT3 receptors. EMBO Rep. 14, 49\u201356 (2013).","journal-title":"EMBO Rep."},{"key":"11142_CR20","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1038\/emboj.2009.227","volume":"28","author":"RE Hibbs","year":"2009","unstructured":"Hibbs, R. E. et al. Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor. EMBO J. 28, 3040\u20133051 (2009).","journal-title":"EMBO J."},{"key":"11142_CR21","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1021\/acschemneuro.6b00132","volume":"7","author":"KL Price","year":"2016","unstructured":"Price, K. L., Lillestol, R. K., Ulens, C. & Lummis, S. C. Palonosetron-5-HT3 receptor interactions as shown by a binding protein cocrystal structure. ACS Chem. Neurosci. 7, 1641\u20131646 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"11142_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nature13552","volume":"512","author":"G Hassaine","year":"2014","unstructured":"Hassaine, G. et al. X-ray structure of the mouse serotonin 5-HT3 receptor. Nature 512, 276\u2013281 (2014).","journal-title":"Nature"},{"key":"11142_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02997-4","volume":"9","author":"S Basak","year":"2018","unstructured":"Basak, S. et al. Cryo-EM structure of 5-HT3A receptor in its resting conformation. Nat. Commun. 9, 514 (2018).","journal-title":"Nat. Commun."},{"key":"11142_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-018-0672-3","volume":"563","author":"L Polovinkin","year":"2018","unstructured":"Polovinkin, L. et al. Conformational transitions of the serotonin 5-HT3 receptor. Nature 563, 275\u2013279 (2018).","journal-title":"Nature"},{"key":"11142_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-018-0660-7","volume":"563","author":"S Basak","year":"2018","unstructured":"Basak, S., Gicheru, Y., Rao, S., Sansom, M. S. P. & Chakrapani, S. Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. Nature 563, 270\u2013274 (2018).","journal-title":"Nature"},{"key":"11142_CR26","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1074\/jbc.274.9.5537","volume":"274","author":"D Yan","year":"1999","unstructured":"Yan, D., Schulte, M. K., Bloom, K. E. & White, M. M. Structural features of the ligand-binding domain of the serotonin 5HT3 receptor. J. Biol. Chem. 274, 5537\u20135541 (1999).","journal-title":"J. Biol. Chem."},{"key":"11142_CR27","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/cb300246j","volume":"7","author":"NH Duffy","year":"2012","unstructured":"Duffy, N. H., Lester, H. A. & Dougherty, D. A. Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis. ACS Chem. Biol. 7, 1738\u20131745 (2012).","journal-title":"ACS Chem. Biol."},{"key":"11142_CR28","doi-asserted-by":"publisher","first-page":"10262","DOI":"10.1021\/bi020266d","volume":"41","author":"DL Beene","year":"2002","unstructured":"Beene, D. L. et al. Cation\u2013pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry 41, 10262\u201310269 (2002).","journal-title":"Biochemistry"},{"key":"11142_CR29","doi-asserted-by":"publisher","first-page":"16576","DOI":"10.1074\/jbc.M601265200","volume":"281","author":"AJ Thompson","year":"2006","unstructured":"Thompson, A. J., Padgett, C. L. & Lummis, S. C. Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop. J. Biol. Chem. 281, 16576\u201316582 (2006).","journal-title":"J. Biol. Chem."},{"key":"11142_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2017.01.023","volume":"119","author":"MD Ruepp","year":"2017","unstructured":"Ruepp, M. D., Wei, H., Leuenberger, M., Lochner, M. & Thompson, A. J. The binding orientations of structurally-related ligands can differ; A cautionary note. Neuropharmacology 119, 48\u201361 (2017).","journal-title":"Neuropharmacology"},{"key":"11142_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0960-894X(00)00670-3","volume":"11","author":"JE Macor","year":"2001","unstructured":"Macor, J. E. et al. The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. Bioorg. Med. Chem. Lett. 11, 319\u2013321 (2001).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"11142_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2004.12.025","volume":"378","author":"RL Papke","year":"2005","unstructured":"Papke, R. L., Schiff, H. C., Jack, B. A. & Horenstein, N. A. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist. Neurosci. Lett. 378, 140\u2013144 (2005).","journal-title":"Neurosci. Lett."},{"key":"11142_CR33","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/sj.emboj.7600828","volume":"24","author":"SB Hansen","year":"2005","unstructured":"Hansen, S. B. et al. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24, 3635\u20133646 (2005).","journal-title":"EMBO J."},{"key":"11142_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1085\/jgp.201210946","volume":"141","author":"P Purohit","year":"2013","unstructured":"Purohit, P. & Auerbach, A. Loop C and the mechanism of acetylcholine receptor-channel gating. J. Gen. Physiol. 141, 467\u2013478 (2013).","journal-title":"J. Gen. Physiol."},{"key":"11142_CR35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1021\/cr00090a003","volume":"88","author":"Y Marcus","year":"1988","unstructured":"Marcus, Y. Ionic radii in aqueous solutions. Chem. Rev. 88, 1475\u20131498 (1988).","journal-title":"Chem. Rev."},{"key":"11142_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.bjp.0705424","volume":"140","author":"AJ Thompson","year":"2003","unstructured":"Thompson, A. J. & Lummis, S. C. A single ring of charged amino acids at one end of the pore can control ion selectivity in the 5-HT3 receptor. Br. J. Pharm. 140, 359\u2013365 (2003).","journal-title":"Br. J. Pharm."},{"key":"11142_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature14853","volume":"526","author":"J Du","year":"2015","unstructured":"Du, J., Lu, W., Wu, S., Cheng, Y. & Gouaux, E. Glycine receptor mechanism elucidated by electron cryo-microscopy. Nature 526, 224\u2013229 (2015).","journal-title":"Nature"},{"issue":"7740","key":"11142_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","volume":"565","author":"Simonas Masiulis","year":"2019","unstructured":"Masiulis, S. et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature https:\/\/doi.org\/10.1038\/s41586-018-0832-5 (2019).","journal-title":"Nature"},{"key":"11142_CR39","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1021\/acs.jctc.6b00201","volume":"12","author":"AJ Clark","year":"2016","unstructured":"Clark, A. J. et al. Prediction of protein-ligand binding poses via a combination of induced fit docking and metadynamics simulations. J. Chem. Theory Comput. 12, 2990\u20132998 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"11142_CR40","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1074\/jbc.275.8.5620","volume":"275","author":"AD Spier","year":"2000","unstructured":"Spier, A. D. & Lummis, S. C. The role of tryptophan residues in the 5-hydroxytryptamine(3) receptor ligand binding domain. J. Biol. Chem. 275, 5620\u20135625 (2000).","journal-title":"J. Biol. Chem."},{"key":"11142_CR41","doi-asserted-by":"publisher","first-page":"15847","DOI":"10.1074\/jbc.M809343200","volume":"284","author":"SA Pless","year":"2009","unstructured":"Pless, S. A. & Lynch, J. W. Ligand-specific conformational changes in the \u03b11 glycine receptor ligand-binding domain. J. Biol. Chem. 284, 15847\u201315856 (2009).","journal-title":"J. Biol. Chem."},{"key":"11142_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/nn926","volume":"5","author":"Y Chang","year":"2002","unstructured":"Chang, Y. & Weiss, D. S. Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism. Nat. Neurosci. 5, 1163 (2002).","journal-title":"Nat. Neurosci."},{"key":"11142_CR43","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1021\/bi500815f","volume":"53","author":"R Yu","year":"2014","unstructured":"Yu, R. et al. Agonist and antagonist binding in human glycine receptors. Biochemistry 53, 6041\u20136051 (2014).","journal-title":"Biochemistry"},{"key":"11142_CR44","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1021\/bi00321a041","volume":"23","author":"D MacKenzie","year":"1984","unstructured":"MacKenzie, D., Arendt, A., Hargrave, P., McDowell, J. H. & Molday, R. S. Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides. Biochemistry 23, 6544\u20136549 (1984).","journal-title":"Biochemistry"},{"key":"11142_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"11142_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1107\/S2059798316019276","volume":"73","author":"R Fernandez-Leiro","year":"2017","unstructured":"Fernandez-Leiro, R. & Scheres, S. H. W. A pipeline approach to single-particle processing in RELION. Acta Crystallogr. D 73, 496\u2013502 (2017).","journal-title":"Acta Crystallogr. D"},{"key":"11142_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S1047-8477(03)00069-8","volume":"142","author":"JA Mindell","year":"2003","unstructured":"Mindell, J. A. & Grigorieff, N. Accurate determination of local defocus and specimen tilt in electron microscopy. J. Struct. Biol. 142, 334\u2013347 (2003).","journal-title":"J. Struct. Biol."},{"key":"11142_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1107\/S205225251801463X","volume":"6","author":"J Zivanov","year":"2019","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5\u201317 (2019).","journal-title":"IUCrJ"},{"key":"11142_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63\u201365 (2014).","journal-title":"Nat. Methods"},{"key":"11142_CR50","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, N.","year":"1994","unstructured":"Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"11142_CR51","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"11142_CR52","first-page":"1948","volume-title":"Acta Crystallogr. Sect. D","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. Sect. D 58, (1948\u20131954 (2002)."},{"key":"11142_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"11142_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0263-7855(97)00009-X","volume":"14","author":"OS Smart","year":"1996","unstructured":"Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph 14, 354\u2013360 (1996). 376.","journal-title":"J. Mol. Graph"},{"key":"11142_CR55","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"11142_CR56","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"11142_CR57","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1021\/jp973084f","volume":"102","author":"AD MacKerell","year":"1998","unstructured":"MacKerell, A. D. et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102, 3586\u20133616 (1998).","journal-title":"J. Phys. Chem. B"},{"key":"11142_CR58","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"11142_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"11142_CR60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"11142_CR61","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"11142_CR62","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"11142_CR63","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover, W. G. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. A 31, 1695\u20131697 (1985).","journal-title":"Phys. Rev. A"},{"key":"11142_CR64","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1021\/acs.jctc.5b00743","volume":"11","author":"MK Scherer","year":"2015","unstructured":"Scherer, M. K. et al. PyEMMA 2: a software package for estimation, validation, and analysis of Markov models. J. Chem. Theory Comput. 11, 5525\u20135542 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"11142_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph 14, 33\u201338 (1996). 27-38.","journal-title":"J. Mol. Graph"},{"key":"11142_CR66","doi-asserted-by":"publisher","first-page":"174101","DOI":"10.1063\/1.4934536","volume":"143","author":"B Trendelkamp-Schroer","year":"2015","unstructured":"Trendelkamp-Schroer, B., Wu, H., Paul, F. & Noe, F. Estimation and uncertainty of reversible Markov models. J. Chem. Phys. 143, 174101 (2015).","journal-title":"J. Chem. Phys."},{"key":"11142_CR67","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","volume":"185","author":"GA Tribello","year":"2014","unstructured":"Tribello, G. A., Massimiliano, B., Branduardi, D., Camilloni, C. & Bussi, G. PLUMED 2: new feathers for an old bird. Comput. Phys. Commun. 185, 604\u2013613 (2014).","journal-title":"Comput. Phys. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11142-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T05:46:34Z","timestamp":1721540794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11142-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["11142"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-11142-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"21 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3225"}}